It is paramount that institutional investors see value in ranking pharmaceutical companies' efforts to improve global access to medicines. These investors are therefore an integral part of the consultation process. As of today, seventeen worldwide investors have pledged their support for more transparency by signing an Investor Statement. Together, these institutional investors manage assets worth USD 2 trillion (as per 31 Dec 2008).
Download a PDF of the Institutional Investor Statement.
As of March 2009, the Investor Statement was signed by the following institutional investors: